Nuro

Neuralink

Nuro

Nuro's business model is delivery-as-a-service. They partner with retailers, restaurants, and grocery chains who pay Nuro to handle last-mile delivery using autonomous vehicles.

Instead of employing human drivers, partners use Nuro's robot fleet.

The economics are compelling on paper. A human delivery driver costs $15-25 per hour including wages, insurance, and vehicle costs.

A Nuro vehicle costs money to build and maintain, but once deployed, it operates nearly 24/7 with no driver wages, no tips, and no breaks. The breakeven point comes when the fleet reaches sufficient utilization in a market.

Revenue also comes from technology licensing. Nuro has partnerships where their autonomy stack could be integrated into other vehicles or platforms.

FedEx, Domino's, Kroger, Walmart, and 7-Eleven have all tested or deployed Nuro vehicles for delivery.

Neuralink

Neuralink doesn't have a traditional revenue model yet — it's still in clinical trials. The near-term plan is medical devices sold to hospitals and clinics for treating neurological conditions.

Brain-computer interfaces for paralysis, ALS, blindness, and other conditions would be reimbursed by insurance and healthcare systems, similar to cochlear implants or deep brain stimulators.

The long-term vision is consumer neurotechnology — healthy people choosing to get brain implants for enhanced cognition, communication, or AI interaction. This is years or decades away and faces massive regulatory and ethical hurdles.

But if it works, the total addressable market is literally every human brain on the planet.

The surgical robot is potentially a separate revenue stream. Even if the implant itself doesn't dominate, the precision robotics technology developed for neural surgery could be licensed to other medical device companies.

Neuralink has also built custom chip fabrication capabilities that could have applications beyond brain interfaces.

Nuro

Dave Ferguson and Jiajun Zhu were both principal engineers at Google's self-driving car project (later Waymo). Ferguson led the machine learning and motion planning teams.

Zhu worked on perception — teaching cars to see and understand the world. They were two of the most senior engineers in autonomous driving.

In 2016, they left Google with a contrarian insight: the hardest part of self-driving cars wasn't the technology. It was the stakes.

A robo-taxi carrying passengers needs to be essentially perfect — any accident could injure or kill someone inside and destroy public trust. But a delivery vehicle carrying groceries?

If it gets in a fender bender, the worst case is squished bananas.

By removing the human from the vehicle, Nuro eliminated the most complex variable in autonomous driving safety. Their vehicles are small, light (under 1,200 pounds), and slow (max 25 mph on surface streets).

If one hits a pedestrian, the impact energy is dramatically lower than a 4,000-pound car going 40 mph. This let them get regulatory approval years before full-size robo-taxis.

The first prototype, R1, looked like a cartoon car — about half the width of a normal vehicle, with no windows, no mirrors, and no driver's seat. Just cargo space and sensors.

They revealed it in 2018 and began testing in Scottsdale, Arizona with Kroger for grocery deliveries.

Neuralink

Elon Musk had been talking about brain-computer interfaces publicly since at least 2016. His stated motivation was existential: if AI becomes superintelligent, humans need a way to merge with it or risk becoming irrelevant.

The solution, in his mind, was a direct neural link between the human brain and computers.

Neuralink was quietly incorporated in July 2016 in California. Musk recruited a team of eight co-founders — neuroscientists, engineers, and chip designers from institutions like UC Berkeley, MIT, and Lawrence Livermore National Laboratory.

The founding team included Ben Rapoport, a neurosurgeon who understood both the medical and engineering sides, and Dongjin Seo, who had done PhD research on neural dust (tiny wireless brain sensors).

The company operated in stealth for two years before a 2019 presentation where Musk revealed the vision: a coin-sized device implanted in the skull containing thousands of ultra-thin electrode threads inserted into the brain by a custom-built surgical robot. The threads are thinner than a human hair — roughly 5 microns wide — and each one contains multiple electrodes that read neural signals.

The robot was necessary because no human surgeon could place threads that thin without damaging brain tissue.

Nuro

Nuro's strategy is to become the default autonomous delivery infrastructure for major retailers. Rather than build a consumer-facing delivery app (competing with DoorDash and Instacart), Nuro provides the robotic fleet that powers deliveries for existing brands.

The partnership-first approach reduces go-to-market friction. Kroger, Walmart, and FedEx already have massive customer bases and order volumes.

Nuro provides the autonomous last-mile delivery layer. The retailer gets lower delivery costs.

Nuro gets guaranteed demand.

Geographic expansion follows a city-by-city playbook. Nuro maps a market, gets regulatory approval, deploys a small fleet, proves reliability, then scales up.

Houston and Mountain View were early markets. The goal is to have fleets operating in major metros across the US.

Neuralink

Neuralink's growth strategy is the classic Musk playbook: start with the premium use case that justifies the cost, then scale down. Phase 1 is medical — treat severe neurological conditions where no other option exists.

Quadriplegia, ALS, locked-in syndrome. Patients who literally cannot move or speak are willing to undergo experimental brain surgery.

The FDA granted Breakthrough Device designation in 2020, and the first human trial (PRIME study) began in 2024.

Phase 2 is expanding medical indications — blindness, depression, epilepsy, Parkinson's. Each new condition multiplies the patient population and the regulatory pathway, building clinical evidence along the way.

Phase 3 — the moonshot — is consumer enhancement. Musk has described this as "conceptual telepathy," where you think a message and it sends.

This phase requires proving extraordinary safety over years of medical use first. Nobody is going to electively implant a brain chip unless the medical version has been proven safe for a decade.

Nuro

The technology still has limitations in complex scenarios. Nuro vehicles operate on surface streets at low speeds — they can't handle highways, heavy snow, or extremely dense urban environments like Manhattan.

This limits the addressable market to suburban deliveries in good weather, which is a large market but not the whole market.

The path to profitability is long. Building custom autonomous vehicles is extraordinarily capital-intensive.

Each generation of vehicle requires hundreds of millions in design, engineering, testing, and manufacturing. Nuro has burned through most of its $2.1 billion in funding and laid off 30% of staff in 2023, signaling the cash crunch is real.

Competition comes from multiple directions. Amazon is developing its own delivery robots (Scout, though paused).

Waymo and Cruise could pivot to autonomous delivery. Established delivery companies could partner with other autonomy providers.

And human drivers remain cheaper than robots at current scale — the economics only flip once Nuro has hundreds or thousands of vehicles per market.

Neuralink

The FDA and regulatory approval process is the primary bottleneck. Brain implants are Class III medical devices — the highest risk category.

Every design change, every new indication, requires extensive clinical data. The USDA also investigated Neuralink in 2022 for potential animal welfare violations in their primate testing program, which created PR headaches.

Long-term biocompatibility is an unsolved problem. The brain treats any foreign object as an invader and forms scar tissue around it, which can degrade signal quality over time.

Making an implant that works reliably for decades inside a hostile biological environment is one of the hardest engineering problems in medicine. Neuralink's thread retraction issue in their first human patient — where some threads pulled away from the brain — highlighted how much work remains.

Talent retention has been rocky. Max Hodak, the original president, left in 2021.

Several founding scientists departed. Working for Musk is notoriously demanding, and the timeline pressure on a medical device company clashes with the inherent need for cautious, methodical development.

Nuro

Nuro R3 — the third-generation autonomous delivery vehicle, purpose-built with no passenger compartment. Larger cargo capacity than R2, improved sensor suite, and designed for commercial-scale manufacturing.

Nuro Autonomy Platform — the self-driving software stack including perception, prediction, planning, and control that runs Nuro's vehicles. Nuro Driver — the AI system that handles all driving decisions in real-time, combining lidar, cameras, radar, and thermal sensors.

Nuro Fleet Management — cloud-based tools for partners to monitor, dispatch, and manage Nuro vehicles across delivery zones.

Neuralink

The N1 Implant — a coin-sized device (23mm diameter, 8mm thick) implanted flush with the skull containing a custom chip that wirelessly transmits neural data to external devices via Bluetooth. The R1 Robot — a precision surgical system that inserts 1,024 electrode threads into the brain with micron-level accuracy, avoiding blood vessels using computer vision.

The N1 User App — software that translates neural signals into computer commands, allowing users to control cursors, keyboards, and eventually robotic limbs through thought alone. BCI Software Platform — the signal processing and machine learning stack that decodes raw brain signals into intended actions.

Nuro

SoftBank Vision Fund led the massive $940 million Series B in 2019. Tiger Global led the Series C at an $8.6 billion valuation.

Greylock Partners and Gaorong Capital were early investors. Alphabet (Google's parent) invested through its venture arm.

Woven Capital (Toyota's investment fund) participated, reflecting automotive industry interest. The company has raised approximately $2.1 billion total.

Neuralink

Elon Musk has been the primary funder, investing hundreds of millions of his personal wealth. The company raised $205 million in a Series C in 2021, then $280 million in a Series D in 2023 led by Founders Fund (Peter Thiel's firm).

A 2024 round reportedly valued the company at $8.9 billion. Google Ventures (GV) and DFJ Growth have also participated.

The investor base is narrow compared to most startups at this valuation.